Articles

Pence’s Obamacare angst may cost state

Even though Obamacare will raise various taxes to subsidize the cost of expanding health insurance coverage, Indiana might say no to all its new funding, to the tune of $1.2 billion per year. That also means the state would say no to a reduction by more than half of the 810,000 Hoosiers that go without health insurance for a time each year.

Read More

Testosterone drugs raise heart risk, study finds

Testosterone replacement drugs, a $1.6 billion market for Eli Lilly and Co. and others, boosted the odds of having a heart attack, stroke or dying by 29 percent in one of the first studies weighing the therapy's cardiovascular risks.

Read More

Lawmakers considering more changes to patent laws

U.S. lawmakers, influenced by companies including Indianapolis-based Eli Lilly and Co., Cisco Systems Inc. and Qualcomm Inc., are considering the second set of patent-law changes in three years as the courts try to race ahead of Congress.

Read More

Builders of Obama’s health website saw red flags

The government spent at least $394 million in contracts to build the federal health care exchange and data hub. The painfully slow and often unresponsive website has frustrated Americans trying to enroll for insurance plans.

Read More

Lilly stock shrugs off analyst downgrade

The drugmaker has become too reliant on its remaining pipeline of drugs under development for growth as it deals with patent expirations to big sellers and drug-development setbacks, a Jefferies analyst wrote.

Read More

City officials aim to build on momentum for cycling

Indianapolis has become a more bike-friendly city, and city planners are looking to ensure the progress continues. The Metropolitan Development Commission will vote Oct. 16 on a bicycle master plan that lays out a host of educational and policy initiatives to encourage two-wheeled transportation.

Read More